Search

Since the beginning of the COVID-19 pandemic, the City of Cambridge has prioritized supporting our unhoused community. Over the past year, we have invested over $11 million in additional funding above the annual $4.5 million to further support our most vulnerable residents.

Today (August 23, 2021), the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals.

Meeting minutes of the Commission for Persons with Disabilities Advisory Board meeting held September 13th, 2012

An overview of the Cambridge Police Department's calls for service on May 1, 2026

Cambridge Police Policy & Procedures

In 2015 the Domestic and Gender Based Violence Prevention Initiative issued a Assets and Needs Assessment Report with Recommendations.

2008 update to 1990 North Cambridge Neighborhood Study.

Fall 2013

The CityView Newsletter is published by the City Manager's Office and mailed to Cambridge residents in April and November. For additional copies, contact Ini Tomeu, Public Information Officer at itomeu@cambridgema.gov.

Recommendations by a 1989 study committee composed of neighborhood residents working with CDD staff covering housing, land use and zoning, urban design, transportation, open space, institutional uses, and economic development.